somatostatin analogCancer Research Peptides
Lanreotide (Somatuline)
A long-acting synthetic somatostatin analog. FDA-approved for acromegaly and gastroenteropancreatic neuroendocrine tumors. Available as a deep subcutaneous depot injection providing sustained release.
somatostatin-analogtumor-treatmentacromegalyneuroendocrine-tumorsFDA-approved
3D Structure
3D Structure
1096.34 Da
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A long-acting synthetic somatostatin analog. FDA-approved for acromegaly and gastroenteropancreatic neuroendocrine tumors. Available as a deep subcutaneous depot injection providing sustained release.